Elite in Primary Hyperoxaluria Type 1

Jerome Harambat

Bordeaux, FR 
Elite in Primary Hyperoxaluria Type 1
Bordeaux, FR 
OverviewLocationsClinical Research

Overview

Jerome Harambat practices in Bordeaux, France. Mr. Harambat is rated as an Elite expert by MediFind in the treatment of Primary Hyperoxaluria Type 1. His top areas of expertise are Nephrocalcinosis, Primary Hyperoxaluria, Primary Hyperoxaluria Type 1, Chronic Kidney Disease, and Kidney Transplant.

His clinical research consists of co-authoring 163 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Primary Hyperoxaluria Type 1.

Gender
Male

Locations

Bordeaux, France
Other Locations
CHU Besançon
Besancon, France
Bron, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Open Label, Multicentre Study, Evaluating the Safety, Tolerability, Efficacy, Compliance and Acceptability of Alkalising Treatments at Long-term in Patients With Cystinuria
Open Label, Multicentre Study, Evaluating the Safety, Tolerability, Efficacy, Compliance and Acceptability of Alkalising Treatments at Long-term in Patients With Cystinuria
Enrollment Status: Withdrawn
Publish Date: March 12, 2024
Intervention Type: Drug
Study Drugs: ADV7103, Standard of Care
Study Phase: Phase 2/Phase 3
A Phase 2 Open-label Multi-centre Study to Evaluate the Efficacy and Safety of Oxabact® to Reduce Plasma Oxalate in Subjects With Primary Hyperoxaluria Who Are on Dialysis
A Phase 2 Open-label Multi-centre Study to Evaluate the Efficacy and Safety of Oxabact® to Reduce Plasma Oxalate in Subjects With Primary Hyperoxaluria Who Are on Dialysis
Enrollment Status: Completed
Publish Date: January 10, 2022
Intervention Type: Biological
Study Phase: Phase 2
Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury
Modalities of Renal Replacement Therapy in Pediatric Acute Kidney Injury
Enrollment Status: Terminated
Publish Date: April 15, 2021
Intervention Type: Procedure
View 2 Less Clinical Trials

159 Total Publications

Corrigendum to "Genotype-Phenotype Correlations in Denys-Drash Syndrome in Children" [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1205-1212].
Corrigendum to "Genotype-Phenotype Correlations in Denys-Drash Syndrome in Children" [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1205-1212].
Journal: Kidney international reports
Published: July 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Harambat's expertise for a condition
ConditionClose
View All 16 Advanced Conditions
View All 38 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile